Delivery Order SPE2DB20D2014-SPE2DB25FC65D
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages, with a contract ceiling value of $1,262.22. This firm fixed price delivery order is expected to be completed by September 12, 2025, and represents a non-set-aside, competitively awarded transaction. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packets, with a ceiling value of $5,294.07. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract's place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. This delivery...
- The Defense Logistics Agency awarded a $2,765.20 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. The contract represents a firm fixed price delivery order with no set-aside designation, reflecting competitive award terms. Performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility by September 17, 2025. This delivery order operates under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Testosterone 50 mg/5 gram packets (unit dose, 5 grams) with a ceiling value of $1,010.68. This is a firm fixed price delivery order with no set-aside designation, utilizing competitive procurement procedures. The order is scheduled for ultimate completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packages, with a ceiling value of $1,274.00. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 8, 2025, and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $2,415.13 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose 5-gram packets. The contract employs firm fixed pricing with no set-aside designation, reflecting a competitive award to the pharmaceutical distributor. The order is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,183.65 to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Testosterone 1% (25mg/2.5g) in unit dose packaging. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting the open competitive procurement process....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Testosterone 1% (25mg/2.5g) in 2.5-gram packages, with a contract value of $1,645.21 and a completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,605.63 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5 gram packages on August 22, 2025, with completion expected by August 25, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical product will be delivered to the company's facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,428.90 to AmerisourceBergen Drug Corp for Testosterone 1% (25mg/2.5g) in 2.5-gram packages on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order, which was competitively awarded without set-aside restrictions, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC65DDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Testosterone 1% (50 mg/5 g) in unit dose packets of 5 grams. This competitively awarded, non-set-aside contract carries a ceiling value of $1,493.80 and represents a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical supply vehicle extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad portfolio of medications and medical supplies to support military and veteran healthcare systems. The contract represents a routine pharmaceutical procurement from the company's substantial prime vendor relationship with DLA, enabling the supply of specialty medications and generic drugs across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/4/25 |